_imbruvica-ibrutinib-140-mg-capsules-cancer-treatment-medication.jpg "Imbruvica Ibrutinib 140 mg Capsules : Cancer Treatment Medication from ibrutinib medication Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 36 sec
✓ Published: 09-Feb-2018
✓ Published: 09-Feb-2018
Description:
Ibrutinib is used to treat certain cancers such as mantle cell lymphoma, chronic lymphocytic leukemia, Waldenstrom's macroglobulinemia. Ibrutinib having strength of 140 mg belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells.nnIbrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system).nnOddway Intern
Ibrutinib is used to treat certain cancers such as mantle cell lymphoma, chronic lymphocytic leukemia, Waldenstrom's macroglobulinemia. Ibrutinib having strength of 140 mg belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells.nnIbrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system).nnOddway Intern
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_the-latest-cll-treatments-and-therapies-with-dr-jan-burger.webp "Leukaemia Foundation - Blood Cancer Information")
_meet-the-new-billionaire-getting-rich-making-injectors-for-blockbuster-drugs-like-ozempic.webp "The runaway success of weight loss drugs took the markets by storm last year, spurring huge stock gains for drugmakers like Novo Nordisk, which makes Wegovy and Ozempic. Most patients take them at home in weekly injections, using plastic, pen-like devices known as autoinjectors, filled with the liquid medication and fitted with a tiny needle as wide as two human hairs.<br/><br/>As demand for the drugs soars, so does the need for those devices. That growth has now minted a new billionaire: Roger Samuelsson, the 60-year-old Swedish cofounder of Switzerland-based SHL Medical, one of the world’s largest manufacturers of autoinjectors. Forbes estimates he’s worth $3 billion, largely thanks to his 69% stake in the company he cofounded in 1989. The remaining 31% is held by Swedish private equity firm EQT—which has minted seven billionaires over the years—and Athos, the family office of the billionaire Struengmann brothers. Press-shy Samuelsson, who declined multiple requests for an interview, also enjoys fast cars (he raced in the 2016 Ferrari Challenge series) and owns the 414-foot megayacht Octopus, which he bought in 2021; the yacht was built for its first owner, Microsoft cofounder Paul Allen (d. 2018).<br/><br/>0:00 Introduction<br/>0:20 Who Is Roger Samuelsson?<br/>3:32 The Growing Market For Injectors<br/>5:50 Who Is The Competition In The Space<br/>8:50 What's Next For SHL Medical<br/>10:45 What's Next For Roger Samuelsson<br/><br/>Read the full story on Forbes: https://www.forbes.com/sites/giacomotognini/2024/04/12/meet-the-billionaire-owned-company-making-injectors-for-blockbuster-drugs-like-ozempic/?sh=5ba1ce857607<br/><br/>Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1<br/><br/>Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:<br/><br/>https://account.forbes.com/membership/?utm_source=youtube&utm_medium=display&utm_campaign=growth_non-sub_paid_subscribe_ytdescript<br/><br/>Stay Connected<br/>Forbes newsletters: https://newsletters.editorial.forbes.com<br/>Forbes on Facebook: http://fb.com/forbes<br/>Forbes Video on Twitter: http://www.twitter.com/forbes<br/>Forbes Video on Instagram: http://instagram.com/forbes<br/>More From Forbes:http://forbes.com<br/><br/>Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.")
⏲ 11:59 👁 4.2M
_calquence-acalabrutinib-ace-cl-001-ibrutinib-intolerant-cohort-dr-raval-md.webp "CALQUENCE (acalabrutinib)")
⏲ 18 minutes 7 seconds 👁 1.2K
_ibrutinib-124-uses-dosage-side-effects-amp-mechanism-124-imbruvica.webp "He-InFo")
_long-term-outcomes-of-patients-with-cll-treated-with-continuous-ibrutinib.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_ibrutinib-treatment-and-its-associated-risk-factors.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_federal-judge-upholds-biden-administration39s-medicare-drug-price-negotiation-program.webp "A federal judge rejected lawsuits from Johnson & Johnson and Bristol Myers Squibb, ruling that the Biden administration's Medicare drug-price negotiation program is constitutional. Drugmakers argued that price negotiations for their drugs by the government violated their freedom of speech and served as an unconstitutional condition for participating in Medicaid and Medicare programs. However, a New Jersey federal judge ruled that participation is voluntary and does not require drugmakers to set aside or transmit drugs at a new price, concluding that reduced profitability does not equate to a physical taking or direct appropriation of their medications.")
_pharmacovigilance-with-ibrutinib-in-chronic-lymphocytic-leukemia.webp "OncLiveTV")
_the-latest-cll-treatments-and-therapies-with-dr-jan-burger.jpg)
_meet-the-new-billionaire-getting-rich-making-injectors-for-blockbuster-drugs-like-ozempic.jpg)
_calquence-acalabrutinib-ace-cl-001-ibrutinib-intolerant-cohort-dr-raval-md.jpg)
_ibrutinib-124-uses-dosage-side-effects-amp-mechanism-124-imbruvica.jpg)
_long-term-outcomes-of-patients-with-cll-treated-with-continuous-ibrutinib.jpg)
_ibrutinib-treatment-and-its-associated-risk-factors.jpg)
_federal-judge-upholds-biden-administration39s-medicare-drug-price-negotiation-program.jpg)
_pharmacovigilance-with-ibrutinib-in-chronic-lymphocytic-leukemia.jpg)
![[+]](/images/menu.gif){kind=small}